Mineralys Therapeutics said on Monday its lead drug significantly lowered blood pressure in patients with difficult-to-treat hypertension in late- and mid-stage trials. The drug, lorundrostat, was ...

A new study from Yeshiva University has revealed a surprising finding—some widely used medications for high blood pressure ...

The results showed that patients taking diltiazem had a 20% higher risk of being hospitalized or dying due to serious ...

Rogaine was approved by the Food and Drug Administration in 1988, the first drug to win the agency’s endorsement for male ...

The FDA has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra ...

Two pivotal trials of the aldosterone synthase inhibitor have shown positive results for lorundrostat in uncontrolled and ...

With hypertension affecting 1.3 billion people worldwide, experts stress that poor diagnosis and treatment adherence continue ...

Losartan may be taken as part of a combination therapy with other medications to lower blood pressure. treat high blood pressure in adults and some children lower the risk of stroke in adults with ...

The hypertension drug rilmenidine has been shown to slow down aging in worms, an effect that in humans could hypothetically help us live longer and keep us healthier in our latter years.

High blood pressure is one of the most common conditions affecting adults in the UK, but many sufferers could benefit from a ...

Mineralys’ shares got a more than 50% boost Monday morning as new data showed its hypertension drug reduced blood pressure in a pair of clinical trials.